Study of AZD4956 as Monotherapy and in Combination with Anti-Cancer Agents in Participants with Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

Trial Identifier:	D8570C00001
Sponsor:	AstraZeneca
Start Date:	February 2026
Primary Completion Date:	July 2029
Study Completion Date:	July 2029
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, VA	Fairfax, VA, US, 22031

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.